Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04964739 · ClinicalTrials.gov registry record · NA
Gender/Sex & CUD Remission
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 224
- Enrollment target
NCT04964739 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 224 participants.
The verdict
NCT04964739, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 224 participants
- Enrollment target
Study Summary
Adults (ages 18+) who would like to reduce their cannabis use (N=224) will be enrolled in an 8-week treatment program. All participants will receive counseling (1 goals session with a therapist followed by 7 weekly computerized cognitive-behavioral therapy sessions). Detailed cannabis assessments (biological and self-report) will be conducted throughout treatment and at 1-, 2-, and 3-months post-treatment completion. Daily electronic diaries will be administered via text message to record detailed logs of cannabis use quantity and frequency. Salivary samples will be collected (and video observed) daily throughout treatment to analyze for progesterone.
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy (CBT4CBT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2021-11-15 |
| Est. Completion | 2025-10-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04964739
The ClinicalTrials.gov registry entry for NCT04964739 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cognitive Behavioral Therapy (CBT4CBT) is the first listed.
NCT04964739 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04964739 about?
NCT04964739 is a clinical study titled "Gender/Sex & CUD Remission". Adults (ages 18+) who would like to reduce their cannabis use (N=224) will be enrolled in an 8-week treatment program. All participants will receive counseling (1 goals session with a therapist followed by 7 weekly computerized cognitive-behavioral therapy sessions). Detailed cannabis assessments (b...
What is the current status of trial NCT04964739?
This trial is currently completed. It is a NA study. The enrollment target is 224 participants. The study started on 2021-11-15. Estimated completion is 2025-10-27.
What interventions are being tested in trial NCT04964739?
The interventions under investigation include: Cognitive Behavioral Therapy (CBT4CBT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04964739?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.